Table 2.
Relation between serum level of omentin-1 (ng/ml) and clinicopathological characteristic of the 120 studied cases.
| Omentin (ng/ml) (mean ± SD) | p value | ||
|---|---|---|---|
| Age | <40 | 179.7 ± 49.2 | 0.002 |
| ≥40 | 333.9 ± 30.8 | ||
|
| |||
| Tumor size | T0-T1 | 161 ± 49.6 | <0.001 |
| T2 | 185.9 ± 41.8 | ||
| T3 | 230.3 ± 43.6 | ||
| T4 | 501.2 ± 397.5 | ||
|
| |||
| Lymph node | N0 | 140.5 ± 20.4 | 0.001 |
| N1 | 198.8 ± 47.2 | ||
| N2 | 224.5 ± 38.1 | ||
| N3 | 514.1 ± 401.4 | ||
| Unknown (X) | 133.2 ± 37.7 | ||
|
| |||
| Metastasis | Yes | 770.5 ± 412.9 | 0.001 |
| No | 203.1 ± 50.5 | ||
|
| |||
| Tumor grade | G1 | 275.1 ± 32.8 | 0.41 |
| G2 | 301.4 ± 279.6 | ||
| G3 | 212.3 ± 35.8 | ||
| Unknown (X) | 448.4 ± 414.5 | ||
|
| |||
| Estrogen receptor (ER) | Positive | 406.5 ± 381.9 | 0.08 |
| Negative | 274.3 ± 208.2 | ||
| Unknown (X) | 184 ± 40.9 | ||
|
| |||
| Progesterone receptor (PR) | Positive | 463.8 ± 420 | 0.15 |
| Negative | 262.6 ± 187.9 | ||
| Unknown (X) | 184 ± 40.9 | ||
| HER2neu | Positive | 283.5 ± 288.5 | 0.85 |
| Negative | 341.9 ± 321.7 | ||
| Unknown (X) | 303.6 ± 278.9 | ||